Rocco Dean Gogliotti

Title: Rocco Dean Gogliotti: Innovator in Pharmaceutical Formulations

Introduction

Rocco Dean Gogliotti is a notable inventor based in Pinckney, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on isothiazolones. With a total of 10 patents to his name, Gogliotti has established himself as a key figure in the development of anti-retroviral and anti-inflammatory agents.

Latest Patents

Gogliotti's latest patents focus on isothiazolones and their pharmaceutical formulations. These compounds have a general structure where A is a monocyclic or bicyclic ring that may contain up to three heteroatoms selected from oxygen, sulfur, and nitrogen. The substituent groups R¹ and R² can include alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy, while R⁵ can be alkyl, cycloalkyl, phenyl, or heteroatom-containing groups. The isothiazolones developed by Gogliotti are recognized for their utility as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents.

Career Highlights

Gogliotti has had a successful career, working at Warner-Lambert Company, where he has been able to apply his expertise in pharmaceutical chemistry. His innovative work has led to the development of important therapeutic agents that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Gogliotti has collaborated with notable colleagues, including Edward Faith Elslager and John Michael Domagala. These collaborations have contributed to the advancement of research and development in the pharmaceutical field.

Conclusion

Rocco Dean Gogliotti is a distinguished inventor whose work in isothiazolones has made a significant impact in the pharmaceutical industry. His contributions continue to influence the development of important medical treatments.